David R. Pelizzon, a director and 10% beneficial owner of OrthoPediatrics Corp. (NASDAQ: KIDS), sold 38,300 shares of common stock for approximately $943,000 through Squadron Capital LLC.
The transactions occurred across August 24-26, with prices ranging from $24.13 to $25.82 per share. On August 24, 4,000 shares were sold at $25.50-$25.82. The following day, 16,300 shares changed hands at $24.53-$24.88. On August 26, 18,000 shares were disposed of at $24.13-$24.36.
The sales were executed by Squadron Capital LLC to provide capital for its other portfolio businesses, according to a regulatory filing. The firm remains a significant shareholder, holding 6,863,464 shares indirectly after the transactions. Pelizzon disclaimed beneficial ownership of Squadron Capital's holdings except to the extent of his pecuniary interest.
OrthoPediatrics' stock has declined 9.3% over the past week, trading at $24.03 per share at the time of the report. The company's 52-week high stands at $26.74. Investment analysis firm InvestingPro has flagged the stock as overvalued relative to its fair value and placed it on its "Most Overvalued" list.
The sales follow the company's strong second-quarter results, where revenue rose 15% year-over-year to a record $70.5 million, exceeding analyst expectations of $68.22 million. Growth was driven by trauma, deformity, and specialty bracing products, though scoliosis revenue declined.
